GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Arcus Biosciences RCUS · USD

Health Care · US listing · 🇺🇸 United States

Compare

18.95

+3.67%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Arcus Biosciences and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Arcus Biosciences RCUS 18.95$2.33bn—-142.9%— +3.67%
Premier PINC 49.41$4.54bn62.32.0%1.63% -0.02%
Adaptive Biotechnologies ADPT 30.26$4.65bn—-21.5%— +8.15%
Neogen NEOG 12.08$2.62bn—-0.9%— +2.72%
10X Genomics TXG 65.05$8.23bn—-6.8%— +9.73%
Immunome IMNM 19.36$2.14bn—-3060.0%— +3.47%
WAVE Life Sciences WVE 3.48$586.9m—-478.3%— +3.26%
Beam Therapeutics BEAM 27.02$2.75bn—-57.2%— +2.31%
Maze Therapeutics MAZE 34.91$1.68bn—31.2%— +2.11%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.